Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme
Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart...
Gespeichert in:
Veröffentlicht in: | Diabetic medicine 2022-01, Vol.39 (1), p.e14733-n/a |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 1 |
container_start_page | e14733 |
container_title | Diabetic medicine |
container_volume | 39 |
creator | Yeoh, Ester Png, Doanna Koh, Pei Ling Sum, Chee Fang Lim, Su Chi Tan, Hwee Huan Ubeynarayana, Chalani Udhyami Subramaniam, Tavintharan |
description | Aims
This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes.
Methods
Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability.
Results
From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c> 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring.
Conclusion
Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c. |
doi_str_mv | 10.1111/dme.14733 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586456930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2611016913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</originalsourceid><addsrcrecordid>eNp1kbFuFDEQhi1ERI5AwQsgSzRJsYm94_Wt6U7hciDlRBGoLe969nDktYO9myg9D47JHRRImWaK-fTNL_2EvOPsnJe5sCOec7EEeEEWXEhRNULxl2TBlqKugC35MXmd8y1jvFagXpFjEFK1omYL8mvj5z5mpKsHkzBgznSKdBsnd28mpCZYug6m80hvop8nF0Omp5vVdn1zRl2g1pkOJ8x0RO_dNGc6Zxd2dPAm_6C7g3uMwU0xlcNHuqK9d8H1xtO7FHfJjCO-IUeD8RnfHvYJ-X61_nb5ubr-uvlyubquemgAqk4hgJJyEKazVtrGqBZ7DrVlAEayAbjqWsFagKXsFSKa1tS1GGwzyJY3cEJO997y-eeMedKjy31JbgLGOeu6aaVopAJW0A__obdxTqGk07XknHGpOBTqbE_1KeaccNB3yY0mPWrO9J9qdKlGP1VT2PcH49yNaP-Rf7sowMUeeHAeH5836U_b9V75G1ull_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2611016913</pqid></control><display><type>article</type><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</creator><creatorcontrib>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</creatorcontrib><description>Aims
This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes.
Methods
Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability.
Results
From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c> 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring.
Conclusion
Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/dme.14733</identifier><identifier>PMID: 34698420</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Awareness ; Blood Glucose - metabolism ; blood glucose monitoring ; Blood Glucose Self-Monitoring - methods ; Diabetes ; diabetes mellitus ; Diabetes mellitus (insulin dependent) ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - drug therapy ; Female ; flash glucose monitoring ; Glucose ; Glucose monitoring ; glucose sensors ; glycaemic variability ; Glycated Hemoglobin A - metabolism ; Humans ; Hypoglycemic Agents - therapeutic use ; Male ; Middle Aged ; Motivation ; Sensors ; Statistical analysis</subject><ispartof>Diabetic medicine, 2022-01, Vol.39 (1), p.e14733-n/a</ispartof><rights>2021 Diabetes UK</rights><rights>2021 Diabetes UK.</rights><rights>Diabetic Medicine © 2022 Diabetes UK</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</citedby><cites>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</cites><orcidid>0000-0002-3361-7512 ; 0000-0002-2686-9412</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdme.14733$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdme.14733$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34698420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeoh, Ester</creatorcontrib><creatorcontrib>Png, Doanna</creatorcontrib><creatorcontrib>Koh, Pei Ling</creatorcontrib><creatorcontrib>Sum, Chee Fang</creatorcontrib><creatorcontrib>Lim, Su Chi</creatorcontrib><creatorcontrib>Tan, Hwee Huan</creatorcontrib><creatorcontrib>Ubeynarayana, Chalani Udhyami</creatorcontrib><creatorcontrib>Subramaniam, Tavintharan</creatorcontrib><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Aims
This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes.
Methods
Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability.
Results
From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c> 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring.
Conclusion
Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</description><subject>Adult</subject><subject>Awareness</subject><subject>Blood Glucose - metabolism</subject><subject>blood glucose monitoring</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Diabetes</subject><subject>diabetes mellitus</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Female</subject><subject>flash glucose monitoring</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>glucose sensors</subject><subject>glycaemic variability</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motivation</subject><subject>Sensors</subject><subject>Statistical analysis</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kbFuFDEQhi1ERI5AwQsgSzRJsYm94_Wt6U7hciDlRBGoLe969nDktYO9myg9D47JHRRImWaK-fTNL_2EvOPsnJe5sCOec7EEeEEWXEhRNULxl2TBlqKugC35MXmd8y1jvFagXpFjEFK1omYL8mvj5z5mpKsHkzBgznSKdBsnd28mpCZYug6m80hvop8nF0Omp5vVdn1zRl2g1pkOJ8x0RO_dNGc6Zxd2dPAm_6C7g3uMwU0xlcNHuqK9d8H1xtO7FHfJjCO-IUeD8RnfHvYJ-X61_nb5ubr-uvlyubquemgAqk4hgJJyEKazVtrGqBZ7DrVlAEayAbjqWsFagKXsFSKa1tS1GGwzyJY3cEJO997y-eeMedKjy31JbgLGOeu6aaVopAJW0A__obdxTqGk07XknHGpOBTqbE_1KeaccNB3yY0mPWrO9J9qdKlGP1VT2PcH49yNaP-Rf7sowMUeeHAeH5836U_b9V75G1ull_A</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Yeoh, Ester</creator><creator>Png, Doanna</creator><creator>Koh, Pei Ling</creator><creator>Sum, Chee Fang</creator><creator>Lim, Su Chi</creator><creator>Tan, Hwee Huan</creator><creator>Ubeynarayana, Chalani Udhyami</creator><creator>Subramaniam, Tavintharan</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3361-7512</orcidid><orcidid>https://orcid.org/0000-0002-2686-9412</orcidid></search><sort><creationdate>202201</creationdate><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><author>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Awareness</topic><topic>Blood Glucose - metabolism</topic><topic>blood glucose monitoring</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Diabetes</topic><topic>diabetes mellitus</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Female</topic><topic>flash glucose monitoring</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>glucose sensors</topic><topic>glycaemic variability</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motivation</topic><topic>Sensors</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeoh, Ester</creatorcontrib><creatorcontrib>Png, Doanna</creatorcontrib><creatorcontrib>Koh, Pei Ling</creatorcontrib><creatorcontrib>Sum, Chee Fang</creatorcontrib><creatorcontrib>Lim, Su Chi</creatorcontrib><creatorcontrib>Tan, Hwee Huan</creatorcontrib><creatorcontrib>Ubeynarayana, Chalani Udhyami</creatorcontrib><creatorcontrib>Subramaniam, Tavintharan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeoh, Ester</au><au>Png, Doanna</au><au>Koh, Pei Ling</au><au>Sum, Chee Fang</au><au>Lim, Su Chi</au><au>Tan, Hwee Huan</au><au>Ubeynarayana, Chalani Udhyami</au><au>Subramaniam, Tavintharan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2022-01</date><risdate>2022</risdate><volume>39</volume><issue>1</issue><spage>e14733</spage><epage>n/a</epage><pages>e14733-n/a</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><abstract>Aims
This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes.
Methods
Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability.
Results
From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c> 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring.
Conclusion
Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34698420</pmid><doi>10.1111/dme.14733</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0002-3361-7512</orcidid><orcidid>https://orcid.org/0000-0002-2686-9412</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0742-3071 |
ispartof | Diabetic medicine, 2022-01, Vol.39 (1), p.e14733-n/a |
issn | 0742-3071 1464-5491 |
language | eng |
recordid | cdi_proquest_miscellaneous_2586456930 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Awareness Blood Glucose - metabolism blood glucose monitoring Blood Glucose Self-Monitoring - methods Diabetes diabetes mellitus Diabetes mellitus (insulin dependent) Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - diagnosis Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Female flash glucose monitoring Glucose Glucose monitoring glucose sensors glycaemic variability Glycated Hemoglobin A - metabolism Humans Hypoglycemic Agents - therapeutic use Male Middle Aged Motivation Sensors Statistical analysis |
title | Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A27%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20Awareness%20to%20Motivate%20and%20Enable%20Solutions%20(GAMES)%20in%20diabetes%20mellitus%20using%20flash%20glucose%20monitoring:%20A%20clinical%20programme&rft.jtitle=Diabetic%20medicine&rft.au=Yeoh,%20Ester&rft.date=2022-01&rft.volume=39&rft.issue=1&rft.spage=e14733&rft.epage=n/a&rft.pages=e14733-n/a&rft.issn=0742-3071&rft.eissn=1464-5491&rft_id=info:doi/10.1111/dme.14733&rft_dat=%3Cproquest_cross%3E2611016913%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2611016913&rft_id=info:pmid/34698420&rfr_iscdi=true |